MRT Regimen - CISMeF

Preferred Label : MRT Regimen;

NCIt synonyms : Methotrexate-Rituximab-Temozolomide; MRT; Methotrexate/Rituximab/Temozolomide; Methotrexate/Temozolomide/Rituximab; MT-R Regimen; MT-R;

NCIt related terms : MT-R (rituximab-rite); MT-R (rituximab-rixi); MT-R (rituximab-arrx); MT-R (rituximab-blit); MT-R (rituximab-abbs); MT-R (rituximab-rixa); MT-R (rituximab-pvvr);

NCIt definition : A regimen consisting of methotrexate, rituximab and temozolomide that can be used in the treatment of central nervous system (CNS) lymphoma.;

NCI Metathesaurus CUI : CL538287;

Codes from synonyms : 10962; 128699; 128071; 127914; 128228; 127757; 128385; 128542;

Détails

Origin ID

C140107;

UMLS CUI

C4553058;

Automatic exact mappings (from CISMeF team)
- 5-methyltetrahydrofolate-homocysteine methyltransferase [ORDO Gene]
- Medial rostrotemporal auditory cortex [FMA entity]
- Nuclear magnetic resonance, not otherwise specified [ICHI means]
- magnetic resonance imaging [MeSH Descriptor]
- renal insufficiency, chronic [MeSH Descriptor]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Methotrexate [NCIt concept]
- Rituximab [NCIt concept]
- Temozolomide [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients